Granules Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Serilingampally, Telangana, India, established in 2020.

2020 Serilingampally, Telangana, India Active

Last Updated: February 22, 2026

About Granules Life Sciences Private Limited

Granules Life Sciences Private Limited, a active private limited company, was established on 18 November 2020 in Serilingampally, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290TG2020PTC146042. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1,000.00 Cr and a paid-up capital of ₹525.00 Cr.

It upholds a compliant status. Employing 23 professional, Its leadership includes Rajiv Pritidas Kakodkar (Director), Chigurupati Krishna Prasad (Director), Umadevi Chigurupati (Director). Past directors included Rajiv Pritidas Kakodkar, Umadevi Chigurupati, Priyanka Chigurupati. It holds ₹400.00 Cr open charges and no settled loans. Its latest AGM occurred on 06 August 2025, with the balance sheet filed on 31 March 2025. It is based at 15Th Floor, Granules Tower, Botanical Garden Road, Serilingampally, Telangana, 500084.

Company Details

CIN/LLPIN
U24290TG2020PTC146042
Registration Number
146042
Incorporation Date
18 November 2020
Authorized Capital
₹1,000.00 Cr
Paid-Up Capital
₹525.00 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1,000.00 Cr as on 22-02-2026
Paid Up Capital ₹ 525.00 Cr as on 22-02-2026
Company Age 5 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 400.00 Cr as on 22-02-2026
Revenue Growth **** 71.69% (FY 2024)
Profit Growth **** -335.20% (FY 2024)
Ebitda **** -271.34% (FY 2024)
Net Worth 275.75% (FY 2024)
Total Assets **** 333.91% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Granules Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Granules Life Sciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rajiv Pritidas Kakodkar	Director	30 Mar 2024	Current
Chigurupati Krishna Prasad	Director	18 Nov 2020	Current
Umadevi Chigurupati	Director	30 Mar 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	04 Aug 2024	Past
Pramod Abcsdd	Additional Director	04 Aug 2024	Past
Pramod Abcsdd	Director	30 Mar 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Granules Life Sciences.

Granules Life Sciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 71.69% increase. The company also saw a substantial fall in profitability, with a 335.2% decrease in profit. The company's net worth Soared by an impressive increase of 275.75%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

71.69%

*******

Revenue from Operations

*******

Total Assets

*******

333.91%

*******

Profit or Loss

*******

-335.20%

*******

Net Worth

*******

275.75%

*******

EBITDA

*******

-271.34%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Granules Life Sciences?

In 2024, Granules Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹4,000,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Sbicap Trustee Company Limited : 400.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 Feb 2024	Sbicap Trustee Company Limited	₹400.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Granules Life Sciences?

Unlock and access historical data on people associated with Granules Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Granules Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Granules Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Granules Life Sciences

Recent Activity within the Organization

Annual General Meeting

Progress on Granules Life Sciences Private Limited last Annual general meeting of members was held on 06 Aug 2025 as per latest MCA records. was documented.
06 Aug 2025
Balance Sheet

The activity Granules Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
31 Mar 2025
Director Appointment

Mukesh Mahavirchand Surana was appointed as a CFO was appointed as a CFO on 19 Apr 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
19 Apr 2024
Director Appointment

Rajiv Pritidas Kakodkar was appointed as a Director was appointed as a Director on 30 Mar 2024 & has been associated with this company since 2 years . was recorded as a recent event.
30 Mar 2024
Director Appointment

The activity Umadevi Chigurupati was appointed as a Director was appointed as a Director on 30 Mar 2024 & has been associated with this company since 2 years . was completed.
30 Mar 2024
Charges

The activity A charge with Sbicap Trustee Company Limited amounted to Rs. 400.00 Cr with Charge ID 100880384 was registered on 20 Feb 2024. was completed.
20 Feb 2024

Explore recent activity and updates - View Recent Activity